Split History
ETFs Holding BPTH »    BPTH Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bio-Path Holdings is a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company utilizing a technology that attains systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Co.'s primary drug candidate, prexigebersen, is in clinical trial for acute myeloid leukemia. Co.'s second drug candidate, Liposomal Bcl2, targets the protein Bcl-2, which is responsible for driving cell survival in a number of cancers. Co.'s third drug candidate, Liposomal Stat3, targets the Stat3 protein and is in preclinical development in a pancreatic patient-derived tumor model. According to our BPTH split history records, Bio-Path Holdings has had 2 splits.
BPTH split history picture
Bio-Path Holdings (BPTH) has 2 splits in our BPTH split history database. The first split for BPTH took place on February 09, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of BPTH owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. BPTH's second split took place on January 18, 2019. This was a 1 for 20 reverse split, meaning for each 20 shares of BPTH owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 5 share position following the split.

When a company such as Bio-Path Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the BPTH split history from start to finish, an original position size of 1000 shares would have turned into 5 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bio-Path Holdings shares, starting with a $10,000 purchase of BPTH, presented on a split-history-adjusted basis factoring in the complete BPTH split history. BPTH split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/11/2009
End date: 12/10/2019
Start price/share: $94.00
End price/share: $7.42
Dividends collected/share: $0.00
Total return: -92.11%
Average Annual Total Return: -22.42%
Starting investment: $10,000.00
Ending investment: $789.22
Years: 10.00
Date Ratio
02/09/20181 for 10
01/18/20191 for 20
BPTH is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

BRLI Split History
BSPM Split History
BSTC Split History
BSX Split History
BTI Split History
BTX Split History
CAH Split History
CALA Split History
CAPR Split History
CASC Split History

Also explore: BPTH shares outstanding history

QuickLogic Corporation (QUIK)
iMedia Brands, Inc. (IMBI)
Akers Biosciences, Inc. (AKER)
NeuroMetrix, Inc. (NURO)
TRACON Pharmaceuticals (TCON)
SELLAS Life Sciences Group, Inc. (SLS)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Camber Energy, Inc. (CEI)
Cancer Genetics, Inc. (CGIX)
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3X Shares (GUSH)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

BPTH Insider Buying

BPTH Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.